NSW needs to mandate masks outdoors, provide adequate financial support, set up a ‘ring of steel’, use rapid tests for essential workers, and ensure cases not in full isolation get to zero, among others.
Articles on COVID-19 vaccines
Displaying 221 - 240 of 596 articles
The effects of Ontario’s compulsory school immunization show there are advantages and disadvantages of requiring vaccination.
Coordinate, motivate, deliver. That’s only the start of the jargon in Australia’s plan to vaccinate the nation.
20-39 year olds are ‘peak spreaders’. If we vaccinate them, it reduces the risk for all of us.
CC BY-NC-ND15.8 MB (download)
Governments should drop the idea of herd immunity. It risks leaving people feeling disillusioned by vaccination campaigns.
Mandating vaccines risks turning a highly effective public health intervention into a contentious battleground — but it also may save lives.
Recovering from COVID and then getting vaccinated, known as hybrid immunity, is more potent than being infected or vaccinated alone.
The circulation of misinformation about the COVID-19 vaccine poses the danger of hampering the government’s efforts to control the pandemic.
Our research shows we are still missing clear and consistent communication about COVID vaccines all Australians can understand and act on.
As high-income countries move into post-vaccination life with vaccination rates of over 80 doses per 100 people, only 1.1 per cent of people in low-income countries have received at least one dose.
The international evidence so far shows COVID vaccines are safe for pregnant women and effective at preventing severe disease.
Vaccine hesitancy is declining in Canada but hasn’t disappeared. New research shows many of those initially less hesitant have since been convinced. With continued efforts, others can still be reached.
Failure to ensure access for all to prevention and treatment, including vaccines, undermines national responses to COVID-19.
Vaccines can’t provide 100% protection, so it’s not a failure or surprise when some vaccinated people get sick with COVID-19. The good news is their cases are much less likely to be severe or fatal.
What kind of vaccine is Sputnik V, how does it work, and what data are we missing?
ATAGI is grappling with competing concerns, considerable uncertainty, and a constantly changing landscape.
The US has split into “two Americas,” one of the unvaccinated and one of the vaccinated. The differences in deaths and hospitalizations between the two populations are striking.
Expensive, opaque and in duplicate. Why company contracts to help the COVID vaccine rollout are such a concern.
Preliminary evidence suggests Lambda has an easier time infecting our cells and is a bit better at dodging our immune systems. But vaccines should still do a good job against it.
A small number of cases of myocarditis and pericarditis have been reported following the mRNA COVID vaccines developed by Pfizer and Moderna. But this is no reason to avoid the jab.
Top contributors
-
Professor, School of Population Health, UNSW
-
Professor, The Children's Hospital at Westmead Clinical School and Sydney Infectious Diseases Institute, University of Sydney
-
Early Career Research Leader, Emerging Viruses, Inflammation and Therapeutics Group, Menzies Health Institute Queensland, Griffith University
-
Professor of Paediatrics and vaccinologist, Royal Childrens Hospital, University of Melbourne and Murdoch Childrens Research Institute (MCRI); Associate Dean International, University of Melbourne, Murdoch Children's Research Institute
-
Professor, School of Social Sciences, The University of Western Australia
-
Associate Professor and ARC Future Fellow, The University of Western Australia
-
Associate professor, Department of Family and Community Medicine, University of Toronto; York University, Canada; University of Sydney
-
Professor, School of Biomedical Sciences and Pharmacy, University of Newcastle
-
Associate Professor, Epidemiology, Deakin University
-
Associate Professor of Health Law, Policy and Management, Boston University
-
Research associate, Warren Alpert Medical School, Brown University, Brown University
-
Chair in Epidemiology, Deakin University
-
Distinguished Professor, Professor of Immunology, RMIT University
-
Vice-Chancellor's Research Fellow, School of Health and Biomedical Sciences, RMIT University
-
Instructor of Human Immunology, Emory University